Ali Fallah-Araghi

Dr. Ali obtained his Ph.D. in Biotechnology from the University of Strasbourg in Andrew Griffiths’ lab developing screening applications for droplet-based microfluidics. Through his Ph.D., he published some of the first in vitro assays for enzyme screening in droplet-based microfluidics and contributed to the development of the technology as a screening tool.

Most recently, Ali worked at Novozymes for 10 years, where he occupied diverse roles such as Science Manager, Department Manager, Scouting for Innovative Technologies, and Technical Service Manager. At Novozymes he spent most of his years in R&D, engaging in-depth with enzyme and microbial screening, as well as expanding his role to the business side working to answer customer projects with strong innovation.